ARTIDENTAL 40 mg/0,01 mg/ml Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

artidental 40 mg/0,01 mg/ml

laboratorios inibsa, s.a. - spania - combinatii (articainum+adrenalinum) - sol. inj. - 40mg/0,01mg/ml - anestezice locale amide

ARTIDENTAL 40 mg/0,005 mg/ml Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

artidental 40 mg/0,005 mg/ml

laboratorios inibsa, s.a. - spania - combinatii (articainum+adrenalinum) - sol. inj. - 40mg/0,005mg/ml - anestezice locale amide

Oxytocin-Richter 5 UI/ml soluţie injectabilă Moldova - rumunų - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

oxytocin-richter 5 ui/ml soluţie injectabilă

gedeon richter plc - oxytocinum - soluţie injectabilă - 5 ui/ml

Yescarta Europos Sąjunga - rumunų - EMA (European Medicines Agency)

yescarta

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - agenți antineoplazici - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Breyanzi Europos Sąjunga - rumunų - EMA (European Medicines Agency)

breyanzi

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - agenți antineoplazici - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

ISOPTIN RR 240 mg Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

isoptin rr 240 mg

famar a.v.e. anthoussa plant - grecia - verapamilum - compr. cu elib. prel. - 240mg - bloc. selective canale calciu cu ef. cardiace directe fenilalchilamine

AMIODARONA ARENA 200 mg Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

amiodarona arena 200 mg

arena group s.a. - romania - amiodaronum - compr. - 200mg - antiaritmice clasa i si iii antiaritmice clasa iii

CISPLATINA ACCORD 1 mg/ml Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

cisplatina accord 1 mg/ml

accord healthcare limited - marea britanie - cisplatinum - conc. pt. sol. perf. - 1mg/ml - alte antineoplazice compusi ai platinei

CLORHIDRAT DE DOPAMINA ZENTIVA 5 mg/ml Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

clorhidrat de dopamina zentiva 5 mg/ml

zentiva s.a. - romania - dopaminum - conc. pt. sol. perf. - 5mg/ml - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice

LIDOCAINA KABI 10 mg/ml Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lidocaina kabi 10 mg/ml

labesfal - laboratÓrios almiro s.a.(fresenius kabi - portugalia - lidocainum - sol. inj. - 10mg/ml - anestezice locale amide